The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis

Min Li,Fang-Jie Zhang,Rui-Jun Bai

DOI: https://doi.org/10.2147/jir.s444758

IF: 4.5

2024-02-19

Journal of Inflammation Research

Abstract:Min Li, 1 Fang-Jie Zhang, 2, 3 Rui-Jun Bai 1 1 Department of Orthopaedics, Wuxi Ninth People's Hospital, Soochow University, Wuxi, Jiangsu, 214000, People's Republic of China; 2 National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, 410008, People's Republic of China; 3 Department of Emergency Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China Correspondence: Rui-Jun Bai, Department of Orthopaedics, Wuxi Ninth People's Hospital, Soochow University, Wuxi, People's Republic of China, Tel +86-15155580215, Fax +86-510-85867999, Email Fang-Jie Zhang, National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Changsha, Hunan, 410008, People's Republic of China, Tel +86-15116256248, Fax +86-871-84327332, Email Arthritis is the most prevalent joint disease and is characterized by articular cartilage degradation, synovial inflammation, and changes in periarticular and subchondral bone. Recent studies have reported that Yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) have significant effects on the proliferation, migration, and survival of chondrocytes and fibroblast-like synovial cells (FLSs). YAP/TAZ signaling pathway, as well as the related Hippo–YAP signaling pathway, are responsible for the condition of cells and articular cartilage in joints. They are tightly regulated to maintain metabolism in chondrocytes and FLSs because abnormal expression may result in cartilage damage. However, the roles and mechanisms of the Hippo–YAP pathway in arthritis remain largely unknown. This review summarizes the roles and key functions of YAP/TAZ and the Hippo–YAP signaling pathway in FLSs and chondrocytes for the induction of proliferation, migration, survival, and differentiation in rheumatoid arthritis (RA) and osteoarthritis (OA) research. We also discuss the therapeutic strategies involving YAP/TAZ and the related Hippo-YAP signaling pathway involved in OA. Keywords: YAP/TAZ, osteoarthritis, rheumatoid arthritis, chondrocytes, therapy Arthritis is the most common musculoskeletal disease in the world. Approximately 9% of the world's adult population is affected by osteoarthritis (OA), which mainly causes joint disability and predominantly affects the joints of the knee, hip and hand. 1,2 Radiographic evidence indicates that OA usually occurs in elderly individuals older than 65 years, while most of them are aged older than 75 years. 3,4 Although OA is often defined as a joint disease characterized by low-grade inflammation and cartilage destruction, its pathogenesis is complex and needs to be fully investigated. OA is a complex joint disorder in which a variety of pathogenic factors contribute to the pathological process. The common factors that induce the initiation and aggravation of OA include chronic mechanical stress, trauma and obesity, which lead to cartilage degeneration, synovial and joint inflammation, subchondral bone sclerosis, and osteophyte formation. 5–7 The extracellular matrix (ECM) and chondrocytes are the main components of articular cartilage, and their functional status is important for joints. Since articular cartilage has a limited capacity for intrinsic repair due to a lack of blood vessels and nerves, chondrocytes exiting only in the ECM are essential for joint health. 8–10 The morphology and function of chondrocytes are altered after receiving external or internal physical or chemical stimulation, leading to increased secretion of enzymes that promote the degradation of the cartilage matrix, such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs). 11–13 These enzymes mainly accelerated the degradation of OA and resulted in catabolic-degrading effects that overwhelm the anabolic-protective function of OA chondrocytes. A large number of proinflammatory cytokines, such as interleukin-1β (IL-1β), tumor necrosis factor (TNF-α) and IL-6, stimulate chondrocytes, and synovial cells secrete inflammatory factors to aggravate articular cartilage and synovial inflammatory responses and promote the progression of OA. 14,15 Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) activated by these inflammatory cytokines not only induce catabolic gene transcription but also stimulate inflammatory mediators such as TNF-α, IL-1β, and IL-6 to accelerate OA via feedback. 16 Recent studies have shown that synovial inflammation is also an important factor in the pathogenesis of rheumatoid arthritis (RA). 15,17,18 The synovial membrane is composed of fibroblast-like synovial cells (FLSs) that line the space betw -Abstract Truncated-

immunology